Ora Banda Mining posts record gold production, cash flow
Ora Banda Mining (ASX:OBM) posted gold production and a surge in cash flow as the Davyhurst Gold Project for the March quarter.
Isaac Francis
Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Articles by Isaac Francis
Technology
Atlantic International scales to $1B run-rate following Circle8 merger
Atlantic International (NASDAQ:ATLN) announced its financial results for the fourth quarter and full year ended December 31, 2025, alongside the transformative completion of its acquisition of Circle8.
-2-640x360.webp&w=3840&q=75)
S&P downgrades ASX rating following ASIC inquiry
S&P Global Ratings has downgraded ASX's (ASX:ASX) long-term issuer credit rating from AA- to A+.
Lightning Minerals pivots to gold at Mt Turner Project
Lightning Minerals (ASX:L1M) designated the wholly owned Mt Turner Project as its flagship asset in a move to become a gold-led explorer.
Bison Resources lists on ASX following $5.5M IPO
Shares in Bison Resources (ASX:BSR) commenced trading on the ASX on April 16 following a heavily oversubscribed $5.5 million initial public offering.
Oil and Gas
Santos Chairman Keith Spence to exit in 2027
Santos (ASX:STO) chairman Keith Spence announced his intention to retire from the board in April 2027.
Brightstar Resources signs Goldfields mining agreement
Brightstar Resources (ASX:BTR) executed a framework agreement with Aquirian (ASX:AQN) for drill and blast services at its Goldfields Hub.
Transport and logistics
Flight Centre completes strategic $200M share buyback
Flight Centre Travel (ASX:FLT) finalised its $200 million on-market share buy-back programme.
Industrials
Alcoa profit jumps on higher aluminum prices and operational milestones
Alcoa Corporation (NYSE:AA) reported a significant improvement in profitability for the first quarter of 2026, bolstered by a favorable pricing environment for aluminum and disciplined operational execution.
Health
Hims & Hers shares surge as FDA schedules landmark peptide review
Hims & Hers Health (NYSE:HIMS) shares surged this week, closing 13.7% higher after the U.S. Food and Drug Administration (FDA) announced a high-stakes meeting to re-evaluate the regulatory status of several popular peptides.